Anne B. Eldrup
18Patents
9h-index
28Co-inventors
72Inventor score
Filing activity: May 23, 1997 → Feb 26, 2019
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7125855B2 | Nucleoside derivatives as inhibitors of RNA-dependent RNA viral polymerase | Emerging Cross-Sectional Technologies | 214 | Expired |
| US6777395B2 | Nucleoside derivatives as inhibitors of RNA-dependent RNA viral polymerase of hepatitis C virus | Emerging Cross-Sectional Technologies | 212 | Expired |
| US7105499B2 | Nucleoside derivatives as inhibitors of RNA-dependent RNA viral polymerase | Emerging Cross-Sectional Technologies | 155 | Expired |
| US7202224B2 | Nucleoside derivatives as inhibitors of RNA-dependent RNA viral polymerase | Emerging Cross-Sectional Technologies | 141 | Active |
| US7323453B2 | Methods of inhibiting orthopoxvirus replication with nucleoside compounds | Human Necessities | 67 | Expired |
| US7534767B2 | C-purine nucleoside analogs as inhibitors of RNA-dependent RNA viral polymerase | Chemistry; Metallurgy | 50 | Expired |
| US8481712B2 | Nucleoside derivatives as inhibitors of RNA-dependent RNA viral polymerase | Emerging Cross-Sectional Technologies | 27 | Active |
| US8604183B2 | Compositions comprising alternating 2′-modified nucleosides for use in gene modulation | Chemistry; Metallurgy | 12 | Active |
| US7812149B2 | 2′-Fluoro substituted oligomeric compounds and compositions for use in gene modulations | Chemistry; Metallurgy | 10 | Expired |
| US7919612B2 | 2′-substituted oligomeric compounds and compositions for use in gene modulations | Emerging Cross-Sectional Technologies | 9 | Expired |
| US6617422B1 | Peptide nucleic acid monomers and oligomers | Chemistry; Metallurgy | 7 | Expired |
| US6632919B1 | Peptide nucleic acid monomers and oligomers | Chemistry; Metallurgy | 5 | Expired |
| US9150605B2 | Compositions comprising alternating 2′-modified nucleosides for use in gene modulation | Chemistry; Metallurgy | 3 | Expired |
| US10266825B2 | Compositions comprising alternating 2′-modified nucleosides for use in gene modulation | Chemistry; Metallurgy | 3 | Active |
| US9150606B2 | Compositions comprising alternating 2'-modified nucleosides for use in gene modulation | Chemistry; Metallurgy | 3 | Expired |
| US8258301B2 | Urotensin II receptor antagonists | Human Necessities | 0 | Active |
| US9771578B2 | Phosphorous-linked oligomeric compounds and their use in gene modulation | Chemistry; Metallurgy | 0 | Active |
| US11078485B2 | Compositions comprising alternating 2′-modified nucleosides for use in gene modulation | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.